GANX position history
The shares of Gain Therapeutics (GANX) that DME Capital Management reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2024 Q1: 566,130 shares, $2.1M, 0.10% of portfolio
- 2024 Q2: 566,130 shares, $725K, 0.04% of portfolio
- 2024 Q3: 566,130 shares, $1M, 0.04% of portfolio
- 2024 Q4: 566,130 shares, $1.2M, 0.06% of portfolio
- 2025 Q1: 566,130 shares, $1.1M, 0.05% of portfolio
- 2025 Q2: 566,130 shares, $1M, 0.04% of portfolio
- 2025 Q3: 566,130 shares, $1M, 0.04% of portfolio
- 2025 Q4: 566,130 shares, $1.8M, 0.06% of portfolio
- 2026 Q1: 566,130 shares, $1.1M, 0.03% of portfolio
- 2026 Q2: 566,130 shares, $1.1M, 0.03% of portfolio
- 2026 Q3: 566,130 shares, $979K, 0.03% of portfolio
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|